RADIOIMMUNOASSAY/BIOMARKERS CORE: Director- M. Reilly The RIA/Biomarkers Core supports the overall mission of the Penn Diabetes Research Center (DRC) to prevent, treat, and cure diabetes mellitus by providing an assay service that has proven essential for diabetes-related research in the DRC. Under the leadership of Drs. Muredach Reilly and Heather Collins, the Core has evolved from a facility that used to be focused mainly on rat and human Insulin, glucagon and C-peptide to a diverse, high-volume and cost-effective service. 100 different diabetes and endocrinology-related markers can be assayed. We believe that performing a large number of radioimmuno-assays and ELISAs in a central core facility rather than in scattered locations throughout the University represents a significant overall savings in equipment and also provides results with better quality. The increase in assays reflects the expansion of diabetes research into the areas of gut hormones, inflammation and obesity and the increased interest in metabolism by the Penn scientific community. Parallel to this increase in assays, the Core has also experienced more investigators using its services. We utilize a charge-back system to recover the cost of the assays and our charges vary from $1.25 to $8 per sample, which are among the lowest of all DRC. The Vision for the RIA/Biomarkers is consolidation and expansion of services through integration with other NIH-cores at Penn, development of new services while enhancing overall quality, and reaching out to a greater number of Penn and Philadelphia diabetes and obesity research investigators. Thus, RIA/Biomarkers Core is a valuable and integral part of the future operation and development of the Penn DRC.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Center Core Grants (P30)
Project #
Application #
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
United States
Zip Code
Brown, Justin C; Troxel, Andrea B; Ky, Bonnie et al. (2016) A randomized phase II dose-response exercise trial among colon cancer survivors: Purpose, study design, methods, and recruitment results. Contemp Clin Trials 47:366-75
Zhang, Yuxiang; Fang, Bin; Damle, Manashree et al. (2016) HNF6 and Rev-erbα integrate hepatic lipid metabolism by overlapping and distinct transcriptional mechanisms. Genes Dev 30:1636-44
Titchenell, Paul M; Quinn, William J; Lu, Mingjian et al. (2016) Direct Hepatocyte Insulin Signaling Is Required for Lipogenesis but Is Dispensable for the Suppression of Glucose Production. Cell Metab 23:1154-66
Ackermann, Amanda M; Wang, Zhiping; Schug, Jonathan et al. (2016) Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes. Mol Metab 5:233-44
Henley, Kathryn D; Stanescu, Diana E; Kropp, Peter A et al. (2016) Threshold-Dependent Cooperativity of Pdx1 and Oc1 in Pancreatic Progenitors Establishes Competency for Endocrine Differentiation and β-Cell Function. Cell Rep 15:2637-50
Tsai, Yu-Cheng; Cooke, Nancy E; Liebhaber, Stephen A (2016) Long-range looping of a locus control region drives tissue-specific chromatin packing within a multigene cluster. Nucleic Acids Res 44:4651-64
Wang, Yue J; Schug, Jonathan; Won, Kyoung-Jae et al. (2016) Single-Cell Transcriptomics of the Human Endocrine Pancreas. Diabetes 65:3028-38
Tomar, Dhanendra; Dong, Zhiwei; Shanmughapriya, Santhanam et al. (2016) MCUR1 Is a Scaffold Factor for the MCU Complex Function and Promotes Mitochondrial Bioenergetics. Cell Rep 15:1673-85
Wang, Yi; Frank, David B; Morley, Michael P et al. (2016) HDAC3-Dependent Epigenetic Pathway Controls Lung Alveolar Epithelial Cell Remodeling and Spreading via miR-17-92 and TGF-β Signaling Regulation. Dev Cell 36:303-15
Shearin, Abigail L; Monks, Bobby R; Seale, Patrick et al. (2016) Lack of AKT in adipocytes causes severe lipodystrophy. Mol Metab 5:472-9

Showing the most recent 10 out of 624 publications